Drug Trial Radar · NCT06929299
A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)
Last checked: Nov 19, 2026Latest source record: Aug 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
56
Planned (sponsor's estimate)
Start
May 12, 2025
Primary completion
Sep 2026
Study completion Sep 2026
Sponsor
- Lead sponsor
- Jiangsu BioJeTay Biotechnology Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Apr 16, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A randomized, double-blind, placebo-controlled design was designed to evaluate the safety and tolerability, pharmacokinetic/pharmacodynamic profile, and immunogenicity of multiple administration of STSA-1301 subcutaneous injection in healthy subjects and patients with ITP, and to further explore the initial efficacy of STSA-1301 subcutaneous injection in patients with ITP
Conditions
- Primary Immune Thrombocytopenia (ITP)
Interventions
STSA-1301 subcutaneous injectionDrug
Subjects will receive the STSA-1301 on the dates specified in the protocol
PlaceboDrug
Subjects will receive the placebo on the dates specified in the protocol
Primary outcomes
What the sponsor says the trial is designed to measure.
- To Evaluate any adverse event that occurs in the subject after administration of the drugTime frame: 78 Days
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Bengbu Medical College
Bengbu, Anhui, China · Recruiting
Peking University People's Hospital
Beijing, Beijing Municipality, China · Recruiting
North China University of Science and Technology Affiliated Hospital
Tangshan, Hebei, China · Recruiting
Henan Cancer Hospital
Zhengzhou, Henan, China · Recruiting
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China · Recruiting
Xi'an Central Hospital
Xi’an, Shanxi, China · Recruiting
Hospital of Hematology, Chinese Academy of Medical Sciences
Tianjin, Tianjin Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.